Thank you and see you next year!

en English

Learning Tracks

Medicare Part D and Opportunities to Increase Biosimilars and Generics Utilization

Monday, November 8, 2021

2:30 p.m. - 3:30 p.m.

Over the past years, Congress has considered a variety of proposals that would modify the Medicare Part D program. While a stark political divide remains on this issue, bipartisan solutions have emerged as a result of the continued work. Speakers in this session will review the policy landscape and discuss changes that would increase generic and biosimilar utilization.

John Brooks, JD
Partner, South Capitol

Sarah D’Orsie
Vice President, Government Affairs and Policy, Fresenius Kabi

Massey Whorley
Associate Principal,  Avalere Health

Skip to content